BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15149563)

  • 1. Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass.
    Balasch J; Fábregues F; Peñarrubia J; Creus M; Manau D; Vidal E; Casamitjana R; Vanrell JA
    Reprod Biomed Online; 2004 Apr; 8(4):408-13. PubMed ID: 15149563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UK.
    Lass A; McVeigh E;
    Reprod Biomed Online; 2004 Dec; 9(6):604-10. PubMed ID: 15670403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
    Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
    BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
    Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
    Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.
    Bühler K; Naether OG; Bilger W
    Reprod Biol Endocrinol; 2014 Jan; 12():6. PubMed ID: 24423045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?
    Driebergen R; Baer G
    Curr Med Res Opin; 2003; 19(1):41-6. PubMed ID: 12661779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.
    Vlaisavljević V; Meden-Vrtovec H; Lewandowski P; Radwan M; Langerova A; Vicena M; Války J; Herman M; Usoniene A; Treijs G
    Curr Med Res Opin; 2010 Apr; 26(4):819-25. PubMed ID: 20121657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment.
    Marrs R; Meldrum D; Muasher S; Schoolcraft W; Werlin L; Kelly E
    Reprod Biomed Online; 2004 Feb; 8(2):175-82. PubMed ID: 14989794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study.
    Sydow P; Gmeinwieser N; Pribbernow K; Keck C; Wiegratz I
    Reprod Biol Endocrinol; 2020 May; 18(1):54. PubMed ID: 32456636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicle-stimulating hormone in clinical practice: an update.
    Daya S
    Treat Endocrinol; 2004; 3(3):161-71. PubMed ID: 16026112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.
    Selman HA; De Santo M; Sterzik K; Coccia E; El-Danasouri I
    Fertil Steril; 2002 Nov; 78(5):1061-7. PubMed ID: 12413994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryo quality based on ovulation induction: defining the differences.
    Racowsky C; Orasanu B; Hinrichsen MJ; Ginsburg ES
    Reprod Biomed Online; 2005 Jul; 11(1):22-5. PubMed ID: 16102282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotrophins--filled-by-mass versus filled-by-bioassay.
    Hugues JN; Durnerin IC
    Reprod Biomed Online; 2005 Jun; 10 Suppl 3():11-7. PubMed ID: 23577410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.